Why does group VII phospholipase A2 increase while types IVA and VIA are specifically inhibited in fatty liver?

OPEN

The differential regulation of phospholipase A2 isoforms shows a complex pattern that lacks mechanistic explanation. This selective regulation likely affects neuroinflammatory eicosanoid production and could impact neurodegenerative processes linked to metabolic syndrome. Gap type: unexplained_observation Source paper: The metabolic cascade leading to eicosanoid precursors--desaturases, elongases, and phospholipases A2--is altered in Zucker fatty rats. (2011, Biochimica et biophysica acta, PMID:21172452)

Priority: 0.73 Domain: neuroinflammation Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: Why does group VII phospholipase A2 increase while types IVA and VIA are specifically inhibited in fatty liver? is a 0.73 priority gap in neuroinflammation. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Why does group VII phospholipase A2 increase while types IVA and VIA are specifically inhibited in fatty liver? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

No knowledge graph edges recorded

🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps